Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(25%)
Results Posted
83%(5 trials)

Phase Distribution

Ph early_phase_1
1
13%
Ph not_applicable
5
63%
Ph phase_2
2
25%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(6)

Detailed Status

Completed6
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 22 (25.0%)
N/A5 (62.5%)

Trials by Status

active_not_recruiting113%
completed675%
recruiting113%

Recent Activity

2 active trials
Showing 5 of 8
completednot_applicable

HYPEROXIA Responses and ROS

NCT05958303
recruitingnot_applicable

Vascular Function and Oxidative Stress in Emergency Medical Responders

NCT06985394
completednot_applicable

Estrogen and Diabetes

NCT03436992
active_not_recruitingnot_applicable

Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)

NCT02115724
completedphase_2

Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease

NCT02774226
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05958303Not Applicable

HYPEROXIA Responses and ROS

Completed
NCT06985394Not Applicable

Vascular Function and Oxidative Stress in Emergency Medical Responders

Recruiting
NCT03436992Not Applicable

Estrogen and Diabetes

Completed
NCT02115724Not Applicable

Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)

Active Not Recruiting
NCT02774226Phase 2

Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease

Completed
NCT01772758Phase 2

Cystic Fibrosis and Endothelial Function: At Rest and During Exercise

Completed
NCT01398943Not Applicable

Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT00860743Early Phase 1

Respiratory and Autonomic Plasticity Following Intermittent Hypoxia

Completed

All 8 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
8